Down-regulation of autophagy-associated protein increased acquired radio-resistance bladder cancer cells sensitivity to taxol

References

• Alfred WJ, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, et al. 2017. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 71(3):462–475.
   PubMed Web of Science ®Google Scholar
• Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, Hernandez V, Kaasinen E, Palou J, Roupret M, et al. 2017. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 71(3):447–461.
   PubMed Web of Science ®Google Scholar
• Chang Y, Xu J, Zhang Q. 2017. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer. Oncol Lett. 14(4):4043–4052.
   PubMed Web of Science ®Google Scholar
• Chen S, Rehman SK, Zhang W, Wen A, Yao L, Zhang J. 2010. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta. 1806(2):220–229.
   PubMed Web of Science ®Google Scholar
• El-Taji OM, Alam S, Hussain SA. 2016. Bladder sparing approaches for muscle-invasive bladder cancers. Curr Treat Opt Oncol. 17(3):15.
   PubMed Web of Science ®Google Scholar
• Gao Y, Guan Z, Chen J, Xie H, Yang Z, Fan J, Wang X, Li L. 2015. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9. Int J Oncol. 47(2):690–700.
   PubMed Web of Science ®Google Scholar
• Ghate K, Brennan K, Karim S, Siemens DR, Mackillop WJ, Booth CM. 2018. Concurrent chemoradiotherapy for bladder cancer: practice patterns and outcomes in the general population. Radiother Oncol. 127(1):136–142.
   PubMed Web of Science ®Google Scholar
• Gil D, Zarzycka M, Dulińska-Litewka J, Ciołczyk-Wierzbicka D, Lekka M, Laidler P. 2019. Dihydrotestosterone increases the risk of bladder cancer in men. Hum Cell. 32(3):379–389.
   PubMed Web of Science ®Google Scholar
• Han S, Zhang S, Chen W. 2013. Analysis of the status and trends of bladder cancer incidence in China. Oncol Prog. 11:89–95.
   Google Scholar
• Jaganathan S, Yue P, Turkson J. 2010. Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src. J Pharmacol Exp Ther. 333(2):373–381.
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, Kurzrock R. 2011. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol. 8(9):528–539.
   PubMed Web of Science ®Google Scholar
• Kaufman DS, Shipley WU, Feldman AS. 2009. Bladder cancer. Lancet. 374(9685):239–249.
   PubMed Web of Science ®Google Scholar
• Liao W, Liu J, Liu B, Huang X, Yin Y, Cai D, Li M, Zhu R. 2018. JIB-04 induces cell apoptosis via activation of the p53/Bcl-2/caspase pathway in MHCC97H and HepG2 cells. Oncol Rep. 40(6):3812–3820.
   PubMed Web of Science ®Google Scholar
• Mao G, Yao Y, Kong Z. 2018. Long term exposure to gammarays induces radioresistance and enhances the migration ability of bladder cancer cells. Mol Med Rep. 18(6):5834–5840.
   PubMed Web of Science ®Google Scholar
• Mathew R, Karantza-Wadsworth V, White E. 2007. Role of autophagy in cancer. Nat Rev Cancer. 7(12):961–967.
   PubMed Web of Science ®Google Scholar
• Miyake M, Morizawa Y, Hori S, Tatsumi Y, Onishi S, Owari T, Iida K, Onishi K, Gotoh D, Nakai Y, et al. 2017. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer. Cancer Sci. 108(11):2221–2228.
   PubMed Web of Science ®Google Scholar
• Ogihara K, Kikuchi E, Yuge K, Ito Y, Tanaka N, Matsumoto K, Miyajima A, Asakura H, Oya M. 2016. Refraining from smoking for 15 years or more reduced the risk of tumor recurrence in non-muscle invasive bladder cancer patients. Ann Surg Oncol. 23(5):1752–1759.
   PubMed Web of Science ®Google Scholar
• Ohori M, Takeuchi M, Maruki R, Nakajima H, Miyake H. 2007. FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice. Naunyn Schmiedebergs Arch Pharmacol. 374(4):311–316.
   PubMed Web of Science ®Google Scholar
• Pasquier B. 2016. Autophagy inhibitors. Cell Mol Life Sci. 73(5):985–1001.
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. 2010. Autophagy and metabolism. Science. 330(6009):1344–1348.
   PubMed Web of Science ®Google Scholar
• Shen YJ, Kong ZL, Wan FN, Wang HK, Bian XJ, Gan HL, Wang CF, Ye DW. 2014. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer. Cancer Sci. 105(6):704–712.
   PubMed Web of Science ®Google Scholar
• Shimura T. 2011. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat Res. 52(5):539–544.
   PubMed Web of Science ®Google Scholar
• Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, Takai Y, Kobayashi J, Komatsu K, Fukumoto M. 2010. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene. 29(34):4826–4837.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA A Cancer J Clin. 70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Soloway MS. 2013. ICUD-EAU International Consultation on Bladder Cancer 2012: recommendations on bladder cancer-progress in a cancer that lacks the limelight. Eur Urol. 63(1):1–3.
   PubMed Web of Science ®Google Scholar
• Wang TH, Wang HS, Soong YK. 2000. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer. 88(11):2619–2628.
   PubMed Web of Science ®Google Scholar
• Weaver BA. 2014. How taxol/paclitaxel kills cancer cells. Mol Biol Cell. 25(18):2677–2681.
   PubMed Web of Science ®Google Scholar
• Wu K, Xie D, Zou Y, Zhang T, Pong RC, Xiao G, Fazli L, Gleave M, He D, Boothman DA, et al. 2013. The mechanism of DAB2IP in chemoresistance of prostate cancer cells. Clin Cancer Res. 19(17):4740–4749.
   PubMed Web of Science ®Google Scholar
• Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y, Yuan H. 2011. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett. 307(2):141–148.
   PubMed Web of Science ®Google Scholar
• Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, et al. 2010. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci USA. 107(6):2485–2490.
   PubMed Web of Science ®Google Scholar
• Yang C, He H, Zhang T, Chen Y, Kong Z. 2016. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ-rays and α-particles in prostate cancer cells. Mol Med Rep. 14(1):567–573.
   PubMed Web of Science ®Google Scholar
• Yang Z, Li C, Fan Z, Liu H, Zhang X, Cai Z, Xu L, Luo J, Huang Y, He L, et al. 2017. Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells. Eur Urol. 71(1):8–12.
   PubMed Web of Science ®Google Scholar
• Yang Z, He L, Lin K, Zhang Y, Deng A, Liang Y, Li C, Wen T. 2017. The KMT1A–GATA3–STAT3 circuit is a novel self-renewal signaling of human bladder cancer stem cells. Clin Cancer Res. 23(21):6673–6685.
   PubMed Web of Science ®Google Scholar
• Yu L, Tumati V, Tseng SF, Hsu FM, Kim DN, Hong D, Hsieh JT, Jacobs C, Kapur P, Saha D. 2012. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia. 14(12):1203–1212.
   PubMed Web of Science ®Google Scholar
• Yun EJ, Baek ST, Xie D, Tseng SF, Dobin T, Hernandez E, Zhou J, Zhang L, Yang J, Sun H, et al. 2015. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1. Oncogene. 34(21):2741–2752.
   PubMed Web of Science ®Google Scholar
• Zhang T, Shen Y, Chen Y, Hsieh JT, Kong Z. 2015. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect. Int J Radiat Biol. 91(4):368–378.
   PubMed Web of Science ®Google Scholar